Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Althaea officinalis ointment for second-degree burn wounds
IRCT20251012067604N1Phase 3Completed
- Sponsor
- Tabriz University of Medical Sciences
- Start
- Nov 2025
- Countries
- 1
01
Overview
Phase 3, open-label trial of Althaea officinalis in burn injury (2 arms), sponsored by Tabriz University of Medical Sciences. Primary endpoints: wound healing at day 28, wound-related pain and 1 more. Started Nov 2025; status: completed.
02
Drugs
Althaea officinalis
03
Conditions
burn injury
Beyond the preview
Go deeper on IRCT20251012067604N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20251012067604N1.